Abstract
Background: Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) can epigenetically regulate lung cancer progression, but its regulatory mechanism in the disease lacks sufficient exploration.
Objective: The study was conducted to probe the regulatory function of IGF2BP3 in lung cancer via modulating the long non-coding RNA CERS6-AS1/microRNA-1202 (CERS6- AS1/miR-1202) axis.
Methods: Clinical samples were collected to evaluate IGF2BP3, CERS6-AS1, miR-1202 and glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) levels. The interactions among IGF2BP3, CERS6-AS1, miR-1202 and GDPD5 were assessed. IGF2BP3-, CERS6-AS1-, and miR-1202-related constructs were transfected into lung cancer cells to determine cell biological functions. Cell tumor formation ability was further detected in vivo.
Results: High expression of IGF2BP3, CERS6-AS1 and GDPD5, and low expression of miR-1202 levels were witnessed in lung cancer tissues. Suppression of IGF2BP3 restrained lung cancer progression. IGF2BP3 positively modulated CERS6-AS1 to regulate miR-1202-targeted GDPD5. Inhibition of CERS6-AS1 or promotion of miR-1202 depressed lung cancer aggravation. CERS6-AS1 silencing or miR-1202 overexpression reversed the impacts induced by IGF2BP3 on lung cancer.
Conclusion: IGF2BP3 facilitates the development of lung cancer cells via binding to the CERS6-AS1 promoter and down-regulating miR-1202, which may be related to GDPD5 upregulation.
Keywords: Lung cancer, Insulin-like growth factor 2 mRNA-binding protein 3, Long non-coding RNA CERS6-AS1, microRNA-1202, Glycerophosphodiester phosphodiesterase domain containing 5
[http://dx.doi.org/10.1016/j.semcdb.2019.06.004] [PMID: 31238096]
[PMID: 33739684]
[http://dx.doi.org/10.1016/j.cnc.2019.05.002] [PMID: 31351552]
[http://dx.doi.org/10.1016/j.mayocp.2019.01.013] [PMID: 31378236]
[http://dx.doi.org/10.3389/fcell.2019.00363] [PMID: 32010687]
[http://dx.doi.org/10.1038/s41375-021-01346-7] [PMID: 34321607]
[http://dx.doi.org/10.3389/fbioe.2020.00679] [PMID: 32984260]
[http://dx.doi.org/10.1089/dna.2020.6136] [PMID: 33493403]
[http://dx.doi.org/10.1002/cam4.2675] [PMID: 31701672]
[http://dx.doi.org/10.1097/MPA.0000000000001806] [PMID: 33939677]
[http://dx.doi.org/10.18632/aging.202540] [PMID: 33581689]
[http://dx.doi.org/10.1016/j.csbj.2021.01.018] [PMID: 33598105]
[http://dx.doi.org/10.1371/journal.pone.0229577] [PMID: 32101576]
[http://dx.doi.org/10.3892/ol.2019.9956] [PMID: 30867774]
[http://dx.doi.org/10.1242/jcs.235044] [PMID: 31932507]
[http://dx.doi.org/10.1007/s00204-016-1847-z] [PMID: 27696134]
[http://dx.doi.org/10.1002/alr.22562] [PMID: 32450008]
[http://dx.doi.org/10.1002/nbm.2766] [PMID: 22279038]
[http://dx.doi.org/10.1186/s13046-019-1316-7] [PMID: 31466523]
[http://dx.doi.org/10.3389/fphar.2021.821567] [PMID: 35111070]
[http://dx.doi.org/10.1002/ctm2.190] [PMID: 33135336]
[http://dx.doi.org/10.1186/s12935-021-02334-8] [PMID: 34823532]
[http://dx.doi.org/10.1016/j.bj.2020.05.010] [PMID: 35166206]
[http://dx.doi.org/10.2147/OTT.S214689] [PMID: 31496733]
[http://dx.doi.org/10.1186/s13046-019-1439-x] [PMID: 31665047]
[http://dx.doi.org/10.1186/s12885-021-08961-8] [PMID: 34774019]
[PMID: 33200535]
[http://dx.doi.org/10.1038/s41419-020-03147-9] [PMID: 33144579]
[http://dx.doi.org/10.1159/000495868] [PMID: 30537731]
[http://dx.doi.org/10.3390/ijms21134569] [PMID: 32604993]
[http://dx.doi.org/10.1186/s12943-017-0647-2] [PMID: 28399871]
[http://dx.doi.org/10.1186/s13046-020-01714-8] [PMID: 32993738]
[http://dx.doi.org/10.3892/ol.2020.11693] [PMID: 32724385]
[http://dx.doi.org/10.3389/fonc.2019.01570] [PMID: 32083017]
[http://dx.doi.org/10.1002/mc.23249] [PMID: 32808708]
[http://dx.doi.org/10.1016/j.immuni.2019.06.025] [PMID: 31315034]
[http://dx.doi.org/10.1038/s41392-021-00658-5] [PMID: 34248142]
[http://dx.doi.org/10.1016/j.jaci.2021.11.024]
[http://dx.doi.org/10.1177/1010428317697565] [PMID: 28443461]
[http://dx.doi.org/10.1016/j.biopha.2017.11.090] [PMID: 29217161]
[http://dx.doi.org/10.1016/j.biopha.2018.03.028] [PMID: 29635904]
[http://dx.doi.org/10.1111/eci.13541] [PMID: 33797091]